mRNA |
MST-312 |
CTRPv2 |
pan-cancer |
AAC |
0.085 |
0.02 |
mRNA |
ceranib-2 |
CTRPv2 |
pan-cancer |
AAC |
0.079 |
0.02 |
mRNA |
canertinib |
CTRPv2 |
pan-cancer |
AAC |
-0.088 |
0.02 |
mRNA |
selumetinib:JQ-1 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.083 |
0.02 |
mRNA |
IPR-456 |
CTRPv2 |
pan-cancer |
AAC |
0.091 |
0.02 |
mRNA |
SRT-1720 |
CTRPv2 |
pan-cancer |
AAC |
0.088 |
0.02 |
mRNA |
isoevodiamine |
CTRPv2 |
pan-cancer |
AAC |
0.076 |
0.02 |
mRNA |
BMS-195614 |
CTRPv2 |
pan-cancer |
AAC |
0.088 |
0.02 |
mRNA |
Vandetanib |
CTRPv2 |
pan-cancer |
AAC |
-0.084 |
0.02 |
mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.084 |
0.02 |